Using a minimum of mathematics and equations and bridging the gap between theory and practice, author Dr. Dutta-Roy provides an in-depth discussion on the technology of cable modems and the services it can offer.
Kirjahaku
Etsi kirjoja tekijän nimen, kirjan nimen tai ISBN:n perusteella.
321 tulosta hakusanalla Amitava Dutta-Roy
Cancer Genetics and Therapeutics
Madhumita Roy; Amitava Datta
Springer Verlag, Singapore
2019
sidottu
The book discusses cancer and the potential use of phytochemicals as cancer therapeutics. It begins with the basics of cancer, including the definition, types, etiology and molecular mechanisms involved, before discussing the fundamentals of diagnosis, treatment and associated problems as well as remedial measures. Since cancer is not a single disease, and the mechanisms of carcinogenesis are different for different cancers, it examines the genes and proteins involved in carcinogenesis, and signal transduction pathways for each individual cancer type. Further, the book reviews the latest research on phytochemicals for cancer treatment, highlighting their anti-cancer properties, sources, structure, active biomolecules and probable mechanisms of action, and describing their biochemical properties in the context of cancer prevention and treatment.
Cancer Genetics and Therapeutics
Madhumita Roy; Amitava Datta
Springer Verlag, Singapore
2020
nidottu
The book discusses cancer and the potential use of phytochemicals as cancer therapeutics. It begins with the basics of cancer, including the definition, types, etiology and molecular mechanisms involved, before discussing the fundamentals of diagnosis, treatment and associated problems as well as remedial measures. Since cancer is not a single disease, and the mechanisms of carcinogenesis are different for different cancers, it examines the genes and proteins involved in carcinogenesis, and signal transduction pathways for each individual cancer type. Further, the book reviews the latest research on phytochemicals for cancer treatment, highlighting their anti-cancer properties, sources, structure, active biomolecules and probable mechanisms of action, and describing their biochemical properties in the context of cancer prevention and treatment.
Genetics and Epigenetics of Breast Cancer
Madhumita Roy; Jaydip Biswas; Amitava Datta
SPRINGER VERLAG, SINGAPORE
2023
sidottu
This book discusses the contribution of genetics and epigenetics alterations in the initiation, development, and recurrence of breast cancer. It also reviews the potential of translating the epigenetic alterations into diagnosis, prognosis, and breast cancer therapy. The initial chapters explore the epigenetics, etiology, and conventional treatment strategies for breast cancer. The subsequent chapters discuss the genetic landscape and cover three main epigenetic modulation mechanisms; histone modification, DNA methylation, and miRNA silencing. Further, the book explores the potential of epigenetic drugs in treating breast cancer. Lastly, it covers the phytochemicals targeting epigenetic modulators in breast cancer treatment. This book is an essential source for researchers and practitioners interested in exploring the potential of epigenetics modulators in breast cancer treatment. ?
Genetics and Epigenetics of Breast Cancer
Madhumita Roy; Jaydip Biswas; Amitava Datta
SPRINGER VERLAG, SINGAPORE
2024
nidottu
This book discusses the contribution of genetics and epigenetics alterations in the initiation, development, and recurrence of breast cancer. It also reviews the potential of translating the epigenetic alterations into diagnosis, prognosis, and breast cancer therapy. The initial chapters explore the epigenetics, etiology, and conventional treatment strategies for breast cancer. The subsequent chapters discuss the genetic landscape and cover three main epigenetic modulation mechanisms; histone modification, DNA methylation, and miRNA silencing. Further, the book explores the potential of epigenetic drugs in treating breast cancer. Lastly, it covers the phytochemicals targeting epigenetic modulators in breast cancer treatment. This book is an essential source for researchers and practitioners interested in exploring the potential of epigenetics modulators in breast cancer treatment. ?
Empowerment of Tribal Women Through Self Help Group
Amitava Dutta; Avik Dey
LAP Lambert Academic Publishing
2012
pokkari
This short, concise work examines alternative paths to economic development-with special reference to the Indian context-from a broad general perspective that relies on theoretical analysis and historical, contemporary development experience, simplified for the non-specialist reader. It first examines alternative meanings of development, distinguishing between the growth of income and production, poverty and distributional issues, happiness, and human functionings and capabilities, and assesses India's performance in terms of these alternative indicators. The book also analyses the main obstacles to economic development that have been identified by development scholars and practitioners, distinguishing between domestic economic factors (such as low levels of domestic saving and investment, inefficiency and stagnant technology, and poverty and inequality), international factors (such as international trade, investment and technology transfers), and non-economic factors (such as historical, political, cultural and social). Finally, it discusses the main strategies for economic development, reviewing debates about the roles of free market and the state, autarkic and open economy approaches, a focus on growth versus a focus on distribution and human development, among others, while arguing against a doctrinaire neoliberal strategy and favouring a balanced approach that pays careful attention to country and time-specific factors.
Growth, Distribution and Uneven Development
Amitava Krishna Dutt
Cambridge University Press
2016
pokkari
This book presents an international study of economic growth and income distribution, with a focus on North-South differences. The text discusses the topic from a purely theoretical perspective, comparing the relations between economies by using formal mathematical models. Four well-known approaches are discussed: neoclassical, neo-Marxian, neo-Keynesian and Kalecki-Steindl. Models are developed to highlight and contrast the basic features of these approaches. Subsequent chapters systematically introduce inflation, technological change, sectoral issues, and international trade, building upon these simple one-sector models. This book will be of value to anyone with an interest in areas such as developmental economics, growth, trade and political economy.
"In this valuable study, an economist and political scientist combine to produce a succinct survey and synthesis of the multidisciplinary literature on happiness and assess its implications for how to improve personal and societal well-being." - Richard Easterlin, University Professor Emeritus USC and creator of the Easterlin paradox "This concise and bracing little book does exactly what it says. It plunges readers into the recent science, economics, and politics of happiness, and will leave them feeling clarified and refreshed." - Darrin M. McMahon, Professor of History at Dartmouth College "This essential book moves beyond the 'happy talk' that marks the tidal wave of self-help books on happiness. Instead Radcliff and Dutt provide an accessible, engaging, and thoroughly multidisciplinary roadmap to the vast scholarly literature on the field of 'happiness science.' There is every reason to expect that the book will be a key reference for scholars and students entering this burgeoning area of research." - George DeMartino, professor of international economics at the University of Denver This book provides a short immersion to the subject of happiness by examining the scholarly literature on it. Among the questions it explores are: What is the meaning of happiness? Is it something that it is possible to understand in general terms, perhaps by distinguishing between different meanings of it, or is it something that is best left to people to define for themselves as they seek to be happy in their own way? Can happiness and its different meanings be measured and, if so, how? On what does happiness depend? Does a person's happiness depend on his or her disposition and individual circumstances, or does it depend in part on how society is organized and on what the government does? Does money buy happiness? What kinds of political, economic, social and environmental factors make people and societies happier? What can people do, either individually or collectively, to become happier?
Keynes’s Third Alternative
Amitava K. Dutt; Edward J. Amadeo
Edward Elgar Publishing Ltd
1990
sidottu
This important new book - the first of its kind - provides a detailed analysis and critical appraisal of the neo-Ricardian Keynesians and the post Keynesians. After placing them in the context of modern schools of macroeconomics, it discusses their contributions including the neo-Ricardian synthesis of Sraffa's ideas on the heterogeneity of capital goods and Keynes's ideas on effective demand, and the post Keyensian analysis of the role of historical time, money and uncertainty in Keynes's work. In conclusion, it suggests a synthesis of their views which could be seen as a starting point for an important challenge to mainstream economics.
NEW DIRECTIONS IN DEVELOPMENT ECONOMICS
Amitava K. Dutt; Kenneth P. Jameson
Edward Elgar Publishing Ltd
1992
sidottu
The decade of the 1980s represented a notable deviation from the widespread and significant development advances of the previous 30 years. This was reflected in an extensive re-examination of the theoretical and empirical bases of development economics.This major new book - written by a group of distinguished economists - provides the new directions needed for confronting the continuing challenge of development. Lance Taylor, Joseph Stiglitz and Amitava Dutt focus primarily on recent theoretical developments and highlight significant advances in several areas especially in new structuralist and new neoclassical approaches. Ajit Singh, Keith Griffin and Kenneth Jameson present a refreshing perspective on the recent experience of developing countries and the prospects of development in coming decades.The main thesis of the book is that the 1980s represented a clear break in the development processes, but the 1990s and beyond hold the possibility of a viable re-direction of development and development economics.
The New Emerging Market Multinationals: Four Strategies for Disrupting Markets and Building Brands
Amitava Chattopadhyay; Rajeev Batra; Aysegul Ozsomer
McGraw-Hill Professional
2012
sidottu
Praise for THE NEW EMERGING-MARKET MULTINATIONALSOne of Strategy and Business’s Best Business Books of the Year"This book is a real eye-opener. It will forever change your assumptions about international economic competition and who the winners will be." —PHILIP KOTLER Kellogg School of Management and author of Winning at Innovation"An insightful read—essential for those wishing to understand the evolution and growth of emerging-economy EMNCs and how they will reshape global market structures."—ANAND MAHINDRA, Vice Chairman and Managing Director, Mahindra Group, India"As this timely book so insightfully points out, the rise of emerging-market multinationals is shifting the global competitive landscape and forcing us to think hard about new growth, strategy, and talent equations. A must-read for business leaders responsible for navigating today's global environment. —MUHTAR KENT, Chairman and Chief Executive Officer, The Coca-Cola Company"This book offers an array of fascinating examples and an interesting framework for stimulating thinking about EMNCs' strategic options." —PANKAJ GHEMAWAT, IESE Business School, and author of World 3.0"A must-read. The book is well researched and provides compelling case illustrations. I highly recommend it." —W. CHAN KIM, Professor, INSEAD; Codirector, INSEAD Blue Ocean Strategy Institute; and bestselling author of Blue Ocean Strategy"This is the future of global competition. You need to understand it if you aspire to be a player or if global markets are now a part of your strategy." —DAVID A. AAKER, Vice Chairman, Prophet, and bestselling author of Brand Relevance"This book gives a clear idea of the success formula of emerging-market multinationals by showing practical insights based on a deep understanding of EMNCs. This will help readers from any type of company structure their own growth strategies."—WONHONG CHO, Executive Vice President and Chief Marketing Officer, Hyundai Motor Company"An excellent collection of ideas and examples that should inspire companies in emerging markets looking to build brands and markets anywhere."—BUSINESSWORLD About the Book:LG. HTC. Tata. Haier. Lenovo. Arcelik. Natura.From smartphones and computers to blue jeans and beer, companies from China, India, Taiwan, Mexico, Turkey, and other emerging markets are now winning leading market shares with their own-branded, high-quality products—rather than with poorly produced products sold under others' brand names. These emerging-market multinational companies (EMNCs) are giving the incumbent market leaders of North America, Western Europe, and Japan a run for their money in the areas of innovation, branding, and marketing.How have these small, under-resourced businesses come so far so quickly? And what can you learn from their strategies and tactics?Renowned experts in global branding and marketing, the authors of The New Emerging-Market Multinationals conducted an in-depth study of 39 EMNCs to reveal the innovative compete-from-below strategies and tactics fueling these companies' meteoric rise. The authors identify four strategies driving this growth:COST LEADERS leverage existing low-cost structures and large-scale volumes to extend their reach into developed markets. KNOWLEDGE LEVERAGERS tap their existing resources and knowledge of home consumers and the market to build branded businesses in other emerging markets.NICHE CUSTOMIZERS combine their cost advantages in manufacturing with newly developed low-cost R&D capabilities to develop customized niche-segment branded offerings in other emerging markets.GLOBAL BRAND BUILDERS use their low-cost manufacturing and R&D capabilities to build branded businesses in developed markets— but limit their focus to specific products and segments through a process of focused innovation.Whether you run an EMNC or a developedmarket company, deep knowledge of the strategies outlined here is an absolute necessity for competing effectively now and in the future. Don't get caught off guard by the "new kids on the block"—because today's EMNCs are determined to be tomorrow's market leaders.
Clinical Chemistry, Immunology and Laboratory Quality Control
Amitava Dasgupta; Amer Wahed
Elsevier Science Publishing Co Inc
2014
sidottu
All pathology residents must have a good command of clinical chemistry, toxicology, immunology, and laboratory statistics to be successful pathologists, as well as to pass the American Board of Pathology examination. Clinical chemistry, however, is a topic in which many senior medical students and pathology residents face challenges. Clinical Chemistry, Immunology and Laboratory Quality Control meets this challenge head on with a clear and easy-to-read presentation of core topics and detailed case studies that illustrate the application of clinical chemistry knowledge to everyday patient care. This basic primer offers practical examples of how things function in the pathology clinic as well as useful lists, sample questions, and a bullet-point format ideal for quick pre-Board review. While larger textbooks in clinical chemistry provide highly detailed information regarding instrumentation and statistics, this may be too much information for students, residents, and clinicians. This book is designed to educate senior medical students, residents, and fellows, and to "refresh" the knowledge base of practicing clinicians on how tests are performed in their laboratories (i.e., method principles, interferences, and limitations).
Alcohol and Its Biomarkers: Clinical Aspects and Laboratory Determination is a concise guide to all currently known alcohol biomarkers, their clinical application, and the laboratory methods used to detect them. Pathologists can use this resource to understand the limitations and cost factors associated with each method for determining certain alcohol biomarkers. In addition, interferences in these determinations are discussed, so that clinicians can understand the causes of falsely elevated biomarkers and pathologists and laboratory scientists can potentially eliminate them. The book focuses on the analytical methods used to detect alcohol in blood and urine, the limitations of alcohol determination using enzymatic methods, and the differences between clinical and forensic alcohol measurement. Chapters also cover cutting-edge alcohol biomarkers for potential use.
Alcohol, Drugs, Genes and the Clinical Laboratory provides an overview and quick reference to genetic relationships and clinical laboratory information related to the serious public health issue of alcohol and drug abuse. Written in a clear and concise manner, this book discusses the necessary information for health and safety professionals working in public health to learn about complex issues quickly to better help their patients, employees, and others affected by alcohol and drug abuse. Alcohol, Drugs, Genes and the Clinical Laboratory covers the important aspects of drugs and alcohol abuse including genetic aspects along with laboratory methods for analysis of alcohol and abused drugs with emphasis on false positive test results. The book is helpful to healthcare professionals, such as pathologists who oversee alcohol and drug testing, emergency room physicians, family practice physicians who are first healthcare professionals who identify patients susceptible to drug and alcohol abuse, and psychiatrists involved with drug and alcohol rehabilitation programs. It will also be useful to safety professionals who have to assess individuals for workplace responsibilities, ranging from police and recruitment to occupational safety and occupational medicine and public health officials.
Antioxidants in Food, Vitamins and Supplements
Amitava Dasgupta; Kimberly Klein
Elsevier Science Publishing Co Inc
2016
nidottu
Antioxidants in Food, Vitamins and Supplements bridges the gap between books aimed at consumers and technical volumes written for investigators in antioxidant research. It explores the role of oxidative stress in the pathophysiology of various diseases as well as antioxidant foods, vitamins, and all antioxidant supplements, including herbal supplements. It offers healthcare professionals a rich resource of key clinical information and basic scientific explanations relevant to the development and prevention of specific diseases. The book is written at an intermediate level, and can be easily understood by readers with a college level chemistry and biology background.
Therapeutic Drug Monitoring Data
Amitava Dasgupta; Matthew Krasowski
Academic Press Inc
2019
nidottu
Therapeutic Drug Monitoring Data: A Concise Guide, Fourth Edition serves as a ready resource of information on commonly monitored drugs that will help readers make decisions relating to the monitoring and interpretation of results. It is an easy-to-read source of information on intended use, pharmacokinetics, therapeutic range, and toxic concentrations, as well as bioavailability, disposition, metabolism and the excretion of commonly monitored therapeutic drugs. This fully updated fourth edition includes sections on new anticonvulsants, anti-depressant and anti-HIV drugs, new drugs for advanced cancer treatment, and thoroughly updated chapters that address new pitfalls and problems in the lab.
Clinical Chemistry, Immunology and Laboratory Quality Control
Amitava Dasgupta; Amer Wahed
Elsevier Science Publishing Co Inc
2021
nidottu
Clinical Chemistry, Immunology and Laboratory Quality Control: A Comprehensive Review for Board Preparation, Certification and Clinical Practice, Second Edition presents core topics and 70 case studies that illustrate the application of clinical chemistry knowledge to everyday patient care. This succinct reference offers practical examples of how things function in the pathology clinic with useful lists, key points, case studies and a bullet point format ideal for quick pre-board review. While larger textbooks in clinical chemistry provide highly detailed information regarding instrumentation and statistics, this book is designed to educate senior medical students, residents and fellows on how tests are performed. This second edition successfully helps pathology residents gain command of clinical chemistry, toxicology, immunology, and laboratory statistics in an effort to help them prepare for the American Board of Pathology examination. Clinical chemistry is a topic in which many senior medical students and pathology residents face challenges.
Biotin and Other Interferences in Immunoassays
Amitava Dasgupta
Elsevier Science Publishing Co Inc
2019
nidottu
Biotin and Other Interferences in Immunoassays: A Concise Guide is aimed at clinical laboratory scientists, medical technologists and pathologists who are often the first individuals contacted by a clinician when a laboratory test result does not correlate with clinical presentation. Research scientists working in diagnostics companies will also find this information essential. Sources of errors in non-immunoassay based methods used in clinical chemistry and toxicology laboratory are also discussed so readers can get all important information from one concise guide. This succinct, user-friendly reference provides the necessary information to address high levels of biotin in clinical laboratory results.
Fighting the Opioid Epidemic: The Role of Providers and the Clinical Laboratory in Understanding Who is Vulnerable covers the important aspects that are essential in fighting the opioid epidemic. This succinct reference highlights how the toxicology laboratory can play a vital role in fighting the opioid epidemic by implementing a robust system for drugs of abuse testing as well as drug testing in pain management patients. It targets health care professionals in a technical manner, discussing polymorphisms of important genes that may be associated with increased vulnerability of alcohol and drug addiction to an individual.